ESAIC Academy

Metabolism of remimazolam in primary human hepatocytes during continuous long-term infusion (five days) in a 3D bioreactor system
ESAIC Academy. Zeilinger K. 05/28/16; 163181; 01AP25-4 Topic: General Anaesthesia
Katrin Zeilinger
Katrin Zeilinger
Login now to access Regular content available to all registered users.
Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies